Ascendis Pharma
#1740
Rank
$10.33B
Marketcap
Denmark
Country
Mr. Jan Moller Mikkelsen (Pres, CEO, Member of Exec. Board & Exec. Director)
Mr. Michael Wolff Jensen L.L.M. (Sr. VP, Chief Legal Officer & Member of the Exec. Board)
Dr. Birgitte Volck M.D., Ph.D. (Sr. VP and Head of Clinical Devel. & Endocrinology Rare Diseases Medical Affairs)
Summary
History
Ascendis Pharma was founded in 2005 in Copenhagen, Denmark with the mission of revolutionizing treatments for rare and complex diseases. The company built a robust platform with state-of-the-art drug development technologies to provide new treatments for diseases with few or no available treatments.
Mission
Vision
Key Team
Mr. Scott T. Smith (CFO, Sr. VP & Member of Exec. Board)
Ms. Lotte Sonderbjerg (Chief Admin. Officer, Sr. VP & Member of the Exec. Board)
Mr. Flemming Steen Jensen (Sr. VP of Product Supply & Quality)
Mr. Peter Rasmussen (VP of Fin. & Principal Accounting Officer)
Dr. Kennett Sprogoe (Sr. VP and Head of Innovation & Research)
Mr. Timothy J. Lee (Sr. Director of Investor Relations)
Dr. Jens Sigurd Okkels Ph.D. (Sr. VP of Product Devel.)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Mr. Jan Moller Mikkelsen (Pres, CEO, Member of Exec. Board & Exec. Director)
Mr. Michael Wolff Jensen L.L.M. (Sr. VP, Chief Legal Officer & Member of the Exec. Board)
Dr. Birgitte Volck M.D., Ph.D. (Sr. VP and Head of Clinical Devel. & Endocrinology Rare Diseases Medical Affairs)